Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Y Yap

Showing results (41-50 of 107) with videos related to

Pageof 11
Sort By:
Cancer Treatment Reports|July 1, 1984
Sequential continuous infusion with doxorubicin and vinblastine: an effective chemotherapy combination for patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate, 5-FU, vincristine, and prednisoneN Tannir, H Y Yap, G H Hortobagyi, et al.
Cancer|July 15, 1982
Treatment for meningeal carcinomatosis in breast cancerH Y Yap, B S Yap, S Rasmussen, et al.
Seminars in Oncology|September 1, 1984
Mitoxantrone, cyclophosphamide, and 5-fluorouracil in the treatment of hormonally unresponsive metastatic breast cancerF A Holmes, H Y Yap, L Esparza, et al.
Cancer Treatment Reports|July 1, 1982
Phase I clinical evaluation of 9,10-anthracenedicarboxyaldehyde[bis(4,5-dihydro-1H-imidazol-2-yl)hydrazone]dihydrochloride (bisantrene)B S Yap, H Y Yap, G R Blumenschein, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1983
Treatment of locoregionally advanced breast cancer with surgery, radiotherapy, and combination chemoimmunotherapyG N Hortobagyi, W Spanos, E D Montague, et al.
Cancer|January 1, 1984
Carminomycin. A new anthracycline analog in the treatment of advanced breast cancerA Aboud, H Y Yap, L Esparza, et al.
Cancer Treatment Reports|September 1, 1981
Vindesine in the treatment of refractory breast cancer: improvement in therapeutic index with continuous 5-day infusionH Y Yap, G R Blumenschein, G P Bodey, et al.
Annals of Internal Medicine|December 1, 1981
Dihydroxyanthracenedione: a promising new drug in the treatment of metastatic breast cancerH Y Yap, G R Blumenschein, F C Schell, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
A comparative study of bisantrene given by two dose schedules in patients with metastatic breast cancerF A Holmes, L Esparza, H Y Yap, et al.
Scientific Reports|July 19, 2022
Activation function 1 of progesterone receptor is required for mammary development and regulation of RANKL during pregnancyShi Hao Lee, Yeannie H Y Yap, Chew Leng Lim, et al.
Pageof 11

Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
Cancer Treatment Reports|July 1, 1984
Sequential continuous infusion with doxorubicin and vinblastine: an effective chemotherapy combination for patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate, 5-FU, vincristine, and prednisoneN Tannir, H Y Yap, G H Hortobagyi, et al.
Cancer|July 15, 1982
Treatment for meningeal carcinomatosis in breast cancerH Y Yap, B S Yap, S Rasmussen, et al.
Seminars in Oncology|September 1, 1984
Mitoxantrone, cyclophosphamide, and 5-fluorouracil in the treatment of hormonally unresponsive metastatic breast cancerF A Holmes, H Y Yap, L Esparza, et al.
Cancer Treatment Reports|July 1, 1982
Phase I clinical evaluation of 9,10-anthracenedicarboxyaldehyde[bis(4,5-dihydro-1H-imidazol-2-yl)hydrazone]dihydrochloride (bisantrene)B S Yap, H Y Yap, G R Blumenschein, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1983
Treatment of locoregionally advanced breast cancer with surgery, radiotherapy, and combination chemoimmunotherapyG N Hortobagyi, W Spanos, E D Montague, et al.
Cancer|January 1, 1984
Carminomycin. A new anthracycline analog in the treatment of advanced breast cancerA Aboud, H Y Yap, L Esparza, et al.
Cancer Treatment Reports|September 1, 1981
Vindesine in the treatment of refractory breast cancer: improvement in therapeutic index with continuous 5-day infusionH Y Yap, G R Blumenschein, G P Bodey, et al.
Annals of Internal Medicine|December 1, 1981
Dihydroxyanthracenedione: a promising new drug in the treatment of metastatic breast cancerH Y Yap, G R Blumenschein, F C Schell, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
A comparative study of bisantrene given by two dose schedules in patients with metastatic breast cancerF A Holmes, L Esparza, H Y Yap, et al.
Scientific Reports|July 19, 2022
Activation function 1 of progesterone receptor is required for mammary development and regulation of RANKL during pregnancyShi Hao Lee, Yeannie H Y Yap, Chew Leng Lim, et al.
Pageof 11